• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼动追踪仪植入成功后的 MRI。

MRI after successful eyeWatch implantation.

机构信息

Swiss Federal Institute of Technology, Lausanne, Switzerland.

Swiss Visio, Montchoisi Clinic, Lausanne, Switzerland.

出版信息

Eur J Ophthalmol. 2022 Jan;32(1):NP79-NP82. doi: 10.1177/1120672120973617. Epub 2020 Nov 13.

DOI:10.1177/1120672120973617
PMID:33183079
Abstract

The eyeWatch is a new glaucoma drainage device that includes an adjustable mechanism that can vary the resistance to aqueous humor outflow during the postoperative period to reduce the burden of postoperative intraocular pressure (IOP) management. The mechanism contains a magnetic rotor that can be adjusted using an external magnetic control unit. Adjustments of the position of the rotor are performed mostly in the initial postoperative follow-up period in order to reach the target IOP. However, for some patients, it might be necessary to perform MRI for the sake of medical investigations. As the MRI is creating a strong magnetic field, this magnetic field is likely to interact with the adjustable rotor of the eyeWatch, resulting in modification of the IOP. We report the case of an 82-old female patient successfully operated with the implantation of an eyeWatch. The patient underwent a cerebral MRI for persistent headache. Shortly after the MRI procedure, the patient was checked at the eye clinic to assess the position of the rotor and to measure the IOP. The eyeWatch was readjusted to the former position set before undergoing the MRI. No complications were reported in the follow-up after MRI. This case demonstrates that MRI examinations can be safely performed after glaucoma surgery using an eyeWatch without compromising on the quality of the imaging or the stability of the IOP. This is a complication-free procedure that only requires checking the new position of the rotor and re-adjusting the implant, if necessary, to achieve the target IOP.

摘要

眼内压监测仪是一种新型青光眼引流装置,包含一个可调节机制,可在术后改变房水流出阻力,以减轻术后眼压(IOP)管理负担。该机制包含一个可通过外部磁控单元进行调节的磁性转子。转子位置的调节主要在术后初期随访期间进行,以达到目标眼压。然而,对于某些患者,出于医疗检查的需要,可能需要进行 MRI。由于 MRI 会产生强磁场,这个磁场可能会与眼内压监测仪的可调转子相互作用,导致眼压发生变化。我们报告了一例成功接受眼内压监测仪植入的 82 岁女性患者的病例。该患者因持续性头痛接受了脑部 MRI 检查。MRI 检查后不久,患者在眼科诊所接受检查,以评估转子位置并测量眼压。眼内压监测仪被重新调整到 MRI 检查前的位置。MRI 检查后随访中未报告任何并发症。本病例表明,在青光眼手术后使用眼内压监测仪进行 MRI 检查是安全的,不会影响成像质量或眼压稳定性。这是一种无并发症的程序,仅需检查转子的新位置,并在必要时重新调整植入物,以达到目标眼压。

相似文献

1
MRI after successful eyeWatch implantation.眼动追踪仪植入成功后的 MRI。
Eur J Ophthalmol. 2022 Jan;32(1):NP79-NP82. doi: 10.1177/1120672120973617. Epub 2020 Nov 13.
2
EyeWatch Rescue of Refractory Hypotony After Baerveldt Drainage Device Implantation: Description of a New Technique.眼内液引流装置植入后难治性低眼压的 EyeWatch 挽救:一种新技术的描述。
J Glaucoma. 2020 Feb;29(2):e7-e10. doi: 10.1097/IJG.0000000000001417.
3
Initial Clinical Results of the eyeWatch: a New Adjustable Glaucoma Drainage Device Used in Refractory Glaucoma Surgery.眼卫士的初步临床结果:一种用于难治性青光眼手术的新型可调式青光眼引流装置。
J Glaucoma. 2019 May;28(5):452-458. doi: 10.1097/IJG.0000000000001209.
4
Comparison Between the eyeWatch Device and the Ahmed Valve in Refractory Glaucoma.眼动仪设备与 Ahmed 阀在难治性青光眼中的比较。
J Glaucoma. 2020 May;29(5):401-405. doi: 10.1097/IJG.0000000000001471.
5
[Clinical results of the eyeWatch system: 1-year outcomes].[eyeWatch系统的临床结果:1年随访结果]
Ophthalmologie. 2024 Apr;121(4):298-307. doi: 10.1007/s00347-024-01994-x. Epub 2024 Feb 16.
6
Eyewatch adjustable drainage device in vitrectomized eyes with refractory glaucoma.用于玻璃体切除术后难治性青光眼患者的眼观可调引流装置
Eur J Ophthalmol. 2023 Nov;33(6):2303-2308. doi: 10.1177/11206721231188153. Epub 2023 Jul 12.
7
Comparison of Efficacy and Complications of Cyclophotocoagulation and Second Glaucoma Drainage Device After Initial Glaucoma Drainage Device Failure.初次青光眼引流装置失败后,睫状体光凝术与二次青光眼引流装置的疗效及并发症比较。
J Glaucoma. 2017 Nov;26(11):1010-1018. doi: 10.1097/IJG.0000000000000766.
8
Surgical outcomes of superior versus inferior glaucoma drainage device implantation.青光眼引流装置植入术上方与下方植入的手术效果比较
J Glaucoma. 2015 Jan;24(1):32-6. doi: 10.1097/IJG.0b013e318287ac8f.
9
[STARflo-a suprachoroidal drainage implant in glaucoma surgery].[STARflo - 一种用于青光眼手术的脉络膜上腔引流植入物]
Ophthalmologe. 2018 Aug;115(8):670-675. doi: 10.1007/s00347-017-0565-0.
10
Endoscopic cyclophotocoagulation versus second glaucoma drainage device after prior aqueous tube shunt surgery.在先前进行房水引流管分流手术后,内镜睫状体光凝术与二次青光眼引流装置的比较。
Clin Exp Ophthalmol. 2017 Apr;45(3):241-246. doi: 10.1111/ceo.12828. Epub 2016 Oct 2.

引用本文的文献

1
Clinical outcomes of the EyeWatch system: three-year results.EyeWatch系统的临床结果:三年期结果
Graefes Arch Clin Exp Ophthalmol. 2025 Aug 16. doi: 10.1007/s00417-025-06942-2.
2
Short term clinical outcomes of the combined eyeWatch™ implant and eyePlate in refractory glaucoma-a United Kingdom dual centre study.联合使用eyeWatch™植入物和eyePlate治疗难治性青光眼的短期临床结果——一项英国双中心研究
Int Ophthalmol. 2025 Jun 24;45(1):258. doi: 10.1007/s10792-025-03573-8.
3
[Clinical results of the eyeWatch system: 1-year outcomes].
[eyeWatch系统的临床结果:1年随访结果]
Ophthalmologie. 2024 Apr;121(4):298-307. doi: 10.1007/s00347-024-01994-x. Epub 2024 Feb 16.
4
Development and material characteristics of glaucoma surgical implants.青光眼手术植入物的研发与材料特性
Adv Ophthalmol Pract Res. 2023 Sep 23;3(4):171-179. doi: 10.1016/j.aopr.2023.09.001. eCollection 2023 Nov-Dec.
5
[Comparison of glaucoma drainage implants].[青光眼引流植入物的比较]
Ophthalmologie. 2023 Apr;120(4):372-377. doi: 10.1007/s00347-023-01846-0. Epub 2023 Apr 25.